These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 11026995

  • 1. Vigabatrin-associated visual field defects in children.
    Russell-Eggitt IM, Mackey DA, Taylor DS, Timms C, Walker JW.
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():334-9. PubMed ID: 11026995
    [Abstract] [Full Text] [Related]

  • 2. Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.
    Werth R, Schädler G.
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3028-35. PubMed ID: 16799049
    [Abstract] [Full Text] [Related]

  • 3. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
    Schmidt T, Rüther K, Jokiel B, Pfeiffer S, Tiel-Wilck K, Schmitz B.
    J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
    [Abstract] [Full Text] [Related]

  • 4. Binasal visual field defects are not specific to vigabatrin.
    Gonzalez P, Sills GJ, Parks S, Kelly K, Stephen LJ, Keating D, Dutton GN, Brodie MJ.
    Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
    [Abstract] [Full Text] [Related]

  • 5. [Visual field changes secondary to vigabatrin treatment].
    Mauri-Llerda JA, Iñiguez C, Tejero-Juste C, Santos-Lasaosa S, Escalza-Cortina I, Ascaso-Puyuelo J, Abad-Alegría F, Morales-Asín F.
    Rev Neurol; 2009 Nov; 31(12):1104-8. PubMed ID: 11205539
    [Abstract] [Full Text] [Related]

  • 6. Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose.
    Kinirons P, Cavalleri GL, O'Rourke D, Doherty CP, Reid I, Logan P, Liggan B, Delanty N.
    Epilepsia; 2006 Feb; 47(2):311-7. PubMed ID: 16499754
    [Abstract] [Full Text] [Related]

  • 7. Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity.
    Moseng L, Sæter M, Mørch-Johnsen GH, Hoff JM, Gajda A, Brodtkorb E, Midelfart A.
    Acta Ophthalmol; 2011 Aug; 89(5):452-8. PubMed ID: 21251242
    [Abstract] [Full Text] [Related]

  • 8. Visual fields in young children treated with vigabatrin.
    Agrawal S, Mayer DL, Hansen RM, Fulton AB.
    Optom Vis Sci; 2009 Jun; 86(6):767-73. PubMed ID: 19417698
    [Abstract] [Full Text] [Related]

  • 9. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
    Mrugacz M, Bakunowicz-Łazarczyk A.
    Klin Oczna; 2003 Jun; 105(5):326-8. PubMed ID: 14746191
    [Abstract] [Full Text] [Related]

  • 10. Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal.
    Newman WD, Tocher K, Acheson JF.
    Eye (Lond); 2002 Sep; 16(5):567-71. PubMed ID: 12194070
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Vigabatrin and visual field defects. A Danish material with evaluation of different screening methods].
    Riise P, Fledelius HC, Rogvi-Hansen Bà.
    Ugeskr Laeger; 2003 Mar 03; 165(10):1034-8. PubMed ID: 12645411
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Study of visual field and vigabatrin treatment in children].
    Pelosse B, Momtchilova M, Roubergue A, Doummar D, Billette de Villemeur T, Laroche L.
    J Fr Ophtalmol; 2001 Dec 03; 24(10):1075-80. PubMed ID: 11913238
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
    Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zackon D.
    Ophthalmology; 1999 Sep 03; 106(9):1792-8. PubMed ID: 10485552
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.